EASTMAN CHEMICAL CO (EMN) Stock Analyst Ratings
USA - NYSE:EMN - US2774321002 - Common Stock
63.78 USD
+1.08 (+1.72%)
62.81 USD
-0.97 (-1.52%)
ChartMill assigns a Buy % Consensus number of 77% to EMN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 78.32. This target is 22.8% above the current price.
EMN was analyzed by 23 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about EMN.
In the previous month the buy percentage consensus was at a similar level.
EMN was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-14 | B of A Securities | Maintains | Buy -> Buy |
| 2025-10-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-03 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-02 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-07 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-08-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-04 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-08-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-01 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-09 | UBS | Maintains | Buy -> Buy |
| 2025-05-28 | UBS | Maintains | Buy -> Buy |
| 2025-04-29 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-28 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-28 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-04-28 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-04-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-07 | UBS | Maintains | Buy -> Buy |
| 2025-04-07 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-04 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-04-03 | Mizuho | Upgrade | Neutral -> Outperform |
| 2025-02-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-02-03 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-02-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-03 | JP Morgan | Maintains | Overweight -> Overweight |
EASTMAN CHEMICAL CO / EMN FAQ
What do analysts expect the price target to be for EASTMAN CHEMICAL CO (EMN)?
23 analysts have analysed EMN and the average price target is 78.32 USD. This implies a price increase of 22.8% is expected in the next year compared to the current price of 63.78.
What is the consensus rating for EASTMAN CHEMICAL CO (EMN) stock?
The consensus rating for EASTMAN CHEMICAL CO (EMN) is 76.5217 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover EASTMAN CHEMICAL CO (EMN) stock?
The number of analysts covering EASTMAN CHEMICAL CO (EMN) is 23.